We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Chemiluminescent Substrate Increases Sensitivity of Western Blot Assays

By LabMedica International staff writers
Posted on 11 May 2010
An extremely sensitive substrate kit for use in procedures to detect proteins by the Western blotting method has now been released to the market.

The PerkinElmer (Waltham, MA, USA) Western Lightning Ultra chemiluminescent substrate kit is a very sensitive system for detection of horseradish peroxidase (HRP) on membranes, with maximum sensitivity in the low femtogram (10-15 g) range. More...
It incorporates a novel enhancer that intensifies a signal generated by peroxidase-catalyzed oxidation of luminol. The substrate produces a signal at 425 nm for at least eight hours, making it ideal for use with a wide variety of CCD (charge-coupled device) imagers as well as Kodak BioMax Light or X-OMAT Blue film. Membranes may be stripped and re-probed for detection of multiple targets.

PerkinElmer maintains that the Western Lighting Ultra reagent produces outstanding sensitivity, a wide dynamic range, and stable signal for assured results in all areas of life sciences research. Additionally, the kit helps reduce the use of primary antibodies by tenfold, providing more information from smaller samples, for faster and more economical research outcomes.

"Life sciences researchers increasingly recognize a growing need for producing data through highly sensitive methods of detecting proteins of interest, under a variety of challenging experimental conditions,” said Dr. Martina Bielefeld-Sévigny, vice president for bio-discovery at PerkinElmer. "We have addressed these needs with the new Western Lighting Ultra detection kit. Researchers can now take advantage of a more stable signal and dynamic range that provides more accurate results. Ultimately, this capability will benefit investigations of potential new drugs, providing deeper insights into their effectiveness against critical diseases.”

Related Links:

PerkinElmer



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.